A detailed history of New Potomac Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, New Potomac Partners, LLC holds 2,287 shares of JNJ stock, worth $355,559. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,287
Previous 3,378 32.3%
Holding current value
$355,559
Previous $493,000 24.95%
% of portfolio
0.19%
Previous 0.27%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$145.48 - $167.38 $158,718 - $182,611
-1,091 Reduced 32.3%
2,287 $370,000
Q2 2024

Jul 17, 2024

SELL
$144.38 - $157.78 $7,219 - $7,889
-50 Reduced 1.46%
3,378 $493,000
Q4 2023

Jan 19, 2024

BUY
$145.6 - $158.88 $308,672 - $336,825
2,120 Added 162.08%
3,428 $537,000
Q3 2023

Oct 17, 2023

SELL
$155.75 - $174.48 $33,642 - $37,687
-216 Reduced 14.17%
1,308 $203,000
Q2 2023

Jul 21, 2023

SELL
$154.35 - $166.11 $15,435 - $16,611
-100 Reduced 6.16%
1,524 $252,000
Q4 2022

Jan 18, 2023

BUY
$160.2 - $179.79 $16,019 - $17,979
100 Added 6.56%
1,624 $0
Q3 2022

Oct 17, 2022

SELL
$161.33 - $179.52 $16,133 - $17,952
-100 Reduced 6.16%
1,524 $249,000
Q1 2022

Apr 25, 2022

SELL
$158.14 - $179.59 $22,139 - $25,142
-140 Reduced 7.94%
1,624 $288,000
Q4 2021

Jan 21, 2022

SELL
$155.93 - $173.01 $76,561 - $84,947
-491 Reduced 21.77%
1,764 $302,000
Q3 2021

Oct 26, 2021

BUY
$161.5 - $179.47 $150,518 - $167,266
932 Added 70.45%
2,255 $364,000
Q4 2020

Jan 28, 2021

SELL
$137.11 - $157.38 $178,654 - $205,066
-1,303 Reduced 49.62%
1,323 $208,000
Q3 2020

Oct 23, 2020

SELL
$140.38 - $153.83 $33,691 - $36,919
-240 Reduced 8.37%
2,626 $391,000
Q2 2020

Aug 04, 2020

SELL
$128.81 - $155.51 $93,387 - $112,744
-725 Reduced 20.19%
2,866 $403,000
Q1 2020

Apr 24, 2020

SELL
$111.14 - $153.99 $41,566 - $57,592
-374 Reduced 9.43%
3,591 $471,000
Q4 2019

Jan 23, 2020

SELL
$127.5 - $146.44 $12,750 - $14,644
-100 Reduced 2.46%
3,965 $578,000
Q3 2019

Oct 21, 2019

SELL
$126.95 - $142.14 $12,695 - $14,213
-100 Reduced 2.4%
4,065 $526,000
Q2 2019

Jul 26, 2019

SELL
$131.15 - $144.24 $19,672 - $21,636
-150 Reduced 3.48%
4,165 $580,000
Q1 2019

Apr 23, 2019

SELL
$125.72 - $139.79 $7,543 - $8,387
-60 Reduced 1.37%
4,315 $603,000
Q2 2018

Aug 03, 2018

SELL
$119.4 - $131.76 $3,582 - $3,952
-30 Reduced 0.68%
4,375 $531,000
Q1 2018

Apr 18, 2018

SELL
$125.1 - $148.14 $40,657 - $48,145
-325 Reduced 6.87%
4,405 $565,000
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $620,670 - $679,322
4,730
4,730 $661,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track New Potomac Partners, LLC Portfolio

Follow New Potomac Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Potomac Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Potomac Partners, LLC with notifications on news.